Fig. 2. SpII*, FANCA and XPF co-localize to discrete nuclear foci after treatment of normal cells with 8-MOP plus UVA light. Normal human lymphoblastoid cells were either undamaged or treated with 8-MOP plus UVA light (6 kJ m^-2) and the localization of SpII*, FANCA and XPF in the nucleus examined 15 hours after treatment with 8-MOP plus UVA. (A) Dual staining was carried out using affinity-purified monoclonal anti--spectrin antibody and affinity-purified polyclonal anti-FANCA antibody, and stained cells were analyzed by immunofluorescence. When the fluorescent signals for SpII* (green) and FANCA (red) are merged, the overlapping foci are yellow, indicating co-localization of these two proteins. (B) An analysis similar to that in (A) was carried out using anti--spectrin antibody (green) and affinity-purified polyclonal anti-XPF antibody (red). Fluorescent signals for both proteins were merged and overlapping foci appear yellow. (C) Dual staining was also carried out using anti-FANCA (green) and anti-XPF (red) antibodies. The fluorescent signals were merged and overlapping foci are yellow. In all of the above experiments, cells were also stained with the appropriate preimmune sera.

Return to article